Hot topics in modern rheumatology
https://doi.org/10.14412/1996-7012-2014-4-96-102
Abstract
The Expert Council for Tofacitinib (TOFA) and two symposiums on New Possibilities for Targeted Therapy of Rheumatoid Arthritis and on Success Factor of Biological Therapy for Rheumatic Diseases were held within the annual scientific-and-practical conference of the V.A. Nasonova Research Institute of Rheumatology on Comorbidity in Rheumatic Diseases in Moscow on 14–15 October 2014.
About the Authors
D. E. Karateev
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
34A, Kashirskoe Shosse, Moscow Russia 115552
Russian Federation
34A, Kashirskoe Shosse, Moscow Russia 115552
E. N. Aleksandrova
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
34A, Kashirskoe Shosse, Moscow Russia 115552
Russian Federation
34A, Kashirskoe Shosse, Moscow Russia 115552
References
1. Charles-Schoeman C, Wicker P, Sechtem U, et al. Cardiovascular safety findings in rheumatoid arthritis patients treated with tofacitinib (CP-690,550), a novel, oral Jak inhibitor. THU0136, EULAR 2012.
2. Cohen S, Tanaka Y, Mariettee X, et al. Integrated Safety Analysis of Tofacitinib in RA Clinical Trials with a Cumulative Exposure of 12664 Patient-years. OP0154. 2014. DOI: 10.1136/annrheumdis-2014-eular.5656.
3. FDA Advisory Committee Meeting, 9 May 2012 (NDA 203214). Briefing book. Available from: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM302960.pdf
4. FDA Advisory Committee Meeting, 9 May 2012 (NDA 203214). Available from: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM304200.pdf
Review
For citations:
Karateev DE, Aleksandrova EN. Hot topics in modern rheumatology. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2014;8(4):96-102. (In Russ.) https://doi.org/10.14412/1996-7012-2014-4-96-102
Views:
3318
Email this article 